Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors by Claudio Vernieri, Claudio Vernieri, Sara Pusceddu, Filippo de Braud, Filippo de Braud

Get full text

Efficacia della combinazione lapatinib-capecitabina in una paziente con carcinoma mammario HER2-positivo metastatico e con resistenza primaria a due linee di terapia con agenti ant... by Claudio Vernieri, Pietro Indelicato, Giuseppe Capri

Get full text

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications by Emma Zattarin, Rita Leporati, Francesca Ligorio, Riccardo Lobefaro, Andrea Vingiani, Giancarlo Pruneri, Claudio Vernieri

Get full text

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer by Martina Dameri, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero, Gabriele Zoppoli

Get full text

HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness by Serenella M. Pupa, Francesca Ligorio, Valeria Cancila, Alma Franceschini, Claudio Tripodo, Claudio Vernieri, Lorenzo Castagnoli

Get full text

Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin by Emma Zattarin, Federico Nichetti, Francesca Ligorio, Francesca Ligorio, Laura Mazzeo, Riccardo Lobefaro, Giovanni Fucà, Giorgia Peverelli, Andrea Vingiani, Andrea Vingiani, Giulia V. Bianchi, Giuseppe Capri, Filippo de Braud, Filippo de Braud, Claudio Vernieri, Claudio Vernieri

Get full text

Beyond <em>LKB1</em> Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment by Cristina Borzi, Giulia Galli, Monica Ganzinelli, Diego Signorelli, Claudio Vernieri, Marina Chiara Garassino, Gabriella Sozzi, Massimo Moro

Get full text

Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications by Francesca Ligorio, Luca Zambelli, Giovanni Fucà, Riccardo Lobefaro, Marzia Santamaria, Emma Zattarin, Filippo de Braud, Claudio Vernieri

Get full text

Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure by Lorenzo Castagnoli, Francesca De Santis, Tatiana Volpari, Claudio Vernieri, Elda Tagliabue, Massimo Di Di Nicola, Serenella M Pupa

Get full text

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential by Sara Pusceddu, Elena Verzoni, Natialie Prinzi, Alessia Mennitto, Daniela Femia, Paolo Grassi, Laura Concas, Claudio Vernieri, Giuseppe Lo Russo, Giuseppe Procopio

Get full text

Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world by Serena Di Cosimo, Eliana La Rocca, Eliana La Rocca, Silva Ljevar, Maria Carmen De Santis, Maria Carmen De Santis, Marta Bini, Marta Bini, Vera Cappelletti, Marta Valenti, Paolo Baili, Filippo G. de Braud, Filippo G. de Braud, Filippo G. de Braud, Secondo Folli, Gianfranco Scaperrotta, Gianfranco Scaperrotta, Chiara Volpi, Chiara Volpi, Chiara Volpi, Andrea Vingiani, Andrea Vingiani, Andrea Vingiani, Claudio Vernieri, Claudio Vernieri, Claudio Vernieri, Paolo Verderio, Rosalba Miceli, Giancarlo Pruneri, Giancarlo Pruneri, Giancarlo Pruneri

Get full text

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence by Aurora Mirabile, Licia Rivoltini, Elena Daveri, Claudio Vernieri, Roberto Mele, Luca Porcu, Chiara Lazzari, Alessandra Bulotta, Maria Grazia Viganò, Stefano Cascinu, Vanesa Gregorc

Get full text

Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical impl... by Claudio Vernieri, Francesca Corti, Federico Nichetti, Francesca Ligorio, Sara Manglaviti, Emma Zattarin, Carmen G. Rea, Giuseppe Capri, Giulia V. Bianchi, Filippo de Braud

Get full text

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up by Claudio Vernieri, Daniela Femia, Sara Pusceddu, Carlo Capella, Juan Rosai, Giuseppina Calareso, Laura Concas, Natalie Prinzi, Giuseppe Lo Russo, Filippo de Braud, Roberto Buzzoni

Get full text

Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers by Maira Di Tano, Franca Raucci, Claudio Vernieri, Irene Caffa, Roberta Buono, Maura Fanti, Sebastian Brandhorst, Giuseppe Curigliano, Alessio Nencioni, Filippo de Braud, Valter D. Longo

Get full text

The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)—Positive Advanced Breast Cancer Treated with First-Line Tax... by Francesca Ligorio, Giovanni Fucà, Emma Zattarin, Riccardo Lobefaro, Luca Zambelli, Rita Leporati, Carmen Rea, Gabriella Mariani, Giulia V. Bianchi, Giuseppe Capri, Filippo de Braud, Claudio Vernieri

Get full text

DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Ce... by Silvia D’Amico, Ewa Krystyna Krasnowska, Isabella Manni, Gabriele Toietta, Silvia Baldari, Giulia Piaggio, Marco Ranalli, Alessandra Gambacurta, Claudio Vernieri, Flavio Di Giacinto, Francesca Bernassola, Filippo de Braud, Maria Lucibello

Get full text

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients by Francesca Ligorio, Luca Zambelli, Achille Bottiglieri, Lorenzo Castagnoli, Emma Zattarin, Riccardo Lobefaro, Arianna Ottini, Andrea Vingiani, Serenella M. Pupa, Giulia V. Bianchi, Giuseppe Capri, Giancarlo Pruneri, Filippo de Braud, Claudio Vernieri

Get full text

The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence by Sara Pusceddu, Claudio Vernieri, Natalie Prinzi, Martina Torchio, Jorgelina Coppa, Maria Antista, Monica Niger, Massimo Milione, Luca Giacomelli, Francesca Corti, Michele Prisciandaro, Michela Monteleone, Elena Colombo, Maria Di Bartolomeo, Filppo de Braud

Get full text

Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study by Sara Pusceddu, Claudio Vernieri, Massimo Di Maio, Natalie Prinzi, Martina Torchio, Francesca Corti, Jorgelina Coppa, Roberto Buzzoni, Maria Di Bartolomeo, Massimo Milione, Benjamin Regnault, Xuan-Mai Truong Thanh, Vincenzo Mazzaferro, Filippo de Braud

Get full text